ATE245451T1 - Xanthangummi enthaltende gelbildende ophthalmische zusammensetzungen - Google Patents

Xanthangummi enthaltende gelbildende ophthalmische zusammensetzungen

Info

Publication number
ATE245451T1
ATE245451T1 AT99913997T AT99913997T ATE245451T1 AT E245451 T1 ATE245451 T1 AT E245451T1 AT 99913997 T AT99913997 T AT 99913997T AT 99913997 T AT99913997 T AT 99913997T AT E245451 T1 ATE245451 T1 AT E245451T1
Authority
AT
Austria
Prior art keywords
xanthang
gum
yellow
compositions containing
ophthalmic compositions
Prior art date
Application number
AT99913997T
Other languages
English (en)
Inventor
Rajan Bawa
Rex E Hall
Bhagwati P Kabra
James E Teague
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Application granted granted Critical
Publication of ATE245451T1 publication Critical patent/ATE245451T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99913997T 1998-04-07 1999-03-26 Xanthangummi enthaltende gelbildende ophthalmische zusammensetzungen ATE245451T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8100498P 1998-04-07 1998-04-07
PCT/US1999/006106 WO1999051273A1 (en) 1998-04-07 1999-03-26 Gelling ophthalmic compositions containing xanthan gum

Publications (1)

Publication Number Publication Date
ATE245451T1 true ATE245451T1 (de) 2003-08-15

Family

ID=22161189

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99913997T ATE245451T1 (de) 1998-04-07 1999-03-26 Xanthangummi enthaltende gelbildende ophthalmische zusammensetzungen

Country Status (19)

Country Link
EP (1) EP1069913B1 (de)
JP (1) JP4545927B2 (de)
KR (1) KR100598722B1 (de)
CN (1) CN1133466C (de)
AR (1) AR016460A1 (de)
AT (1) ATE245451T1 (de)
AU (1) AU740586B2 (de)
BR (1) BR9910113A (de)
CA (1) CA2322579C (de)
DE (1) DE69909768T2 (de)
DK (1) DK1069913T3 (de)
ES (1) ES2203103T3 (de)
HK (1) HK1031335A1 (de)
NZ (1) NZ506921A (de)
PT (1) PT1069913E (de)
TR (1) TR200002848T2 (de)
TW (1) TWI262797B (de)
WO (1) WO1999051273A1 (de)
ZA (1) ZA200004413B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
AU2797400A (en) * 1999-01-19 2000-08-07 Dr. Gerhard Mann Chemisch-Pharmazeutische Fabrik Gmbh Artificial lacrimal fluid in gel form
JP2003513046A (ja) 1999-11-01 2003-04-08 アルコン，インコーポレイテッド フルオロキノロン抗生薬およびキサンタンガムを含有する薬学的組成物
ATE291913T1 (de) * 2000-01-25 2005-04-15 Alcon Inc Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
US6458836B1 (en) 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
CN100506232C (zh) * 2000-03-16 2009-07-01 苏坎波公司 用于治疗眼压过高和青光眼的组合物
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
JP2004503593A (ja) 2000-07-14 2004-02-05 アラーガン、インコーポレイテッド 増大した溶解度を持つ治療活性成分を含む組成物
IL151530A0 (en) 2000-07-14 2003-04-10 Allergan Sales Inc Compositions containing alpha-2-adrenergic agonist components
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension
CN1218689C (zh) 2000-07-28 2005-09-14 爱尔康公司 包含妥布霉素和黄原胶的药物组合物
AU2001217709B2 (en) * 2000-11-16 2005-10-13 Alcon Manufacturing, Ltd. Combination therapy for lowering and controlling intraocular pressure
US6919321B2 (en) 2000-12-20 2005-07-19 Alcon, Inc. Ophthalmic lubricating solution adapted for use in lasik surgery
AU2002230504A1 (en) 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic irrigating solution adapted for use in lasik surgery
US7084130B2 (en) 2001-12-11 2006-08-01 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
AU2895502A (en) 2000-12-20 2002-07-01 Alcon Universal Ltd Solution for removing cataracts via liquefracture
AU2003215820A1 (en) * 2002-03-28 2003-10-13 Sucampo Ag Method for treating ocular hypertension and glaucoma
US7030149B2 (en) * 2002-04-19 2006-04-18 Allergan, Inc. Combination of brimonidine timolol for topical ophthalmic use
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
EP2404606A1 (de) * 2003-08-21 2012-01-11 Sucampo AG Ophthalmische Zusammensetzungen enthaltend eine Prostaglandine und ein Viskositätsmittel
US7939511B2 (en) 2004-09-28 2011-05-10 Senju Pharmaceutical Co., Ltd. Ophthalmic composition containing xanthan gum and amino acid
WO2007032997A1 (en) * 2005-09-13 2007-03-22 Bausch & Lomb Incorporated Ophthalmic formulation containing loteprednol etabonate for treatment of dry eye
US7875271B2 (en) 2006-03-23 2011-01-25 Senju Pharmaceutical Co., Ltd. Ophthalmic composition comprising xanthan gum and glucose
KR20090057223A (ko) 2006-07-31 2009-06-04 센주 세이야꾸 가부시키가이샤 아미드 화합물을 함유하는 수성 액제
CN101547695B (zh) 2006-10-12 2011-04-27 杏林制药株式会社 具有改进的加替沙星眼内渗透性的含水液体制剂
TWI544934B (zh) * 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
DE102010009475B4 (de) 2010-02-26 2011-11-24 F. Holzer Gmbh Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates
CN102970973A (zh) * 2010-05-07 2013-03-13 太阳医药高级研发有限公司 新型眼用组合物
JP5713791B2 (ja) * 2010-05-12 2015-05-07 テイカ製薬株式会社 眼科用剤
CN102946855B (zh) * 2010-06-23 2016-01-06 爱尔康研究有限公司 含有妥布霉素和***的局部用眼科混悬剂
US20130149394A1 (en) * 2010-08-27 2013-06-13 Wakamoto Pharmaceutical Co., Ltd. Aqueous ophthalmic composition
US20170368192A1 (en) 2014-10-13 2017-12-28 Symic Ip, Llc Luminal vessel coating for arteriovenous fistula
WO2016061145A1 (en) 2014-10-13 2016-04-21 Symic Biomedical, Inc. Synthetic proteoglycans for preventing tissue adhesion
WO2016065083A1 (en) 2014-10-21 2016-04-28 Symic Biomedical, Inc. Peptidoglycans comprising collagen-binding peptides for treating gastroesophageal injury
CN104825386A (zh) * 2015-05-25 2015-08-12 湖北汇瑞药业股份有限公司 一种表皮麻醉凝胶及其制备方法
WO2017066349A1 (en) 2015-10-13 2017-04-20 Symic Ip, Llc Ve-cadherin binding bioconjugate
KR101770324B1 (ko) 2016-11-09 2017-08-22 주식회사태준제약 안압 강하용 점안 조성물
CN109722347B (zh) * 2019-01-03 2020-12-29 山东省药学科学院 一种含有黄原胶的保湿润滑组合物及其应用
KR20240045074A (ko) * 2022-09-29 2024-04-05 주식회사태준제약 브리모니딘을 포함하는 안과용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4814160A (en) * 1988-03-01 1989-03-21 Colgate-Palmolive Company Non-bleeding striped dentifrice
US6093420A (en) * 1996-07-08 2000-07-25 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs

Also Published As

Publication number Publication date
ZA200004413B (en) 2001-05-22
AU740586B2 (en) 2001-11-08
TWI262797B (en) 2006-10-01
CA2322579C (en) 2001-08-28
ES2203103T3 (es) 2004-04-01
JP4545927B2 (ja) 2010-09-15
DK1069913T3 (da) 2003-11-17
NZ506921A (en) 2002-02-01
CN1295483A (zh) 2001-05-16
HK1031335A1 (en) 2001-06-15
EP1069913B1 (de) 2003-07-23
CN1133466C (zh) 2004-01-07
DE69909768T2 (de) 2004-06-17
AR016460A1 (es) 2001-07-04
KR100598722B1 (ko) 2006-07-11
KR20010041473A (ko) 2001-05-25
DE69909768D1 (de) 2003-08-28
JP2002510654A (ja) 2002-04-09
CA2322579A1 (en) 1999-10-14
BR9910113A (pt) 2000-12-26
WO1999051273A1 (en) 1999-10-14
EP1069913A1 (de) 2001-01-24
TR200002848T2 (tr) 2001-02-21
AU3194799A (en) 1999-10-25
PT1069913E (pt) 2003-11-28

Similar Documents

Publication Publication Date Title
ATE245451T1 (de) Xanthangummi enthaltende gelbildende ophthalmische zusammensetzungen
DE69932177D1 (de) Dentalbleichzusammensetzung
ID26720A (id) Komposisi oral
ID20233A (id) Komposisi oral
DE69807756T2 (de) Fotopolymerisierbare dentalzusammensetzungen
FI963421A0 (fi) Oraalisia apuainekoostumuksia
DE69831962D1 (de) Ophthalmische zusammensetzungen für weiche kontaklinsen enthaltend terpenoid
BR9508844A (pt) Composição oral
ID19097A (id) Komposisi-komposisi oral
FI963051A0 (fi) Paroksetiiniresinaattia sisältäviä oraalisia nestekoostumuksia
FI954867A (fi) Purukumi
DE69902040D1 (de) Zahnwiederherstellungsmaterial
TR199501447A2 (tr) Oral bilesimler.
DE69902998D1 (de) Dentalschleifmittel
BR9506536A (pt) Composição oral
DE69739369D1 (de) Kaugummizusammensetzung
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
DE19983575T1 (de) Zahnseide
DE69929921D1 (de) Zahnwurzelkanalinstrument
BR9510467A (pt) Composições orais
NO20020319L (no) Oftalmisk sammensetning
DK1023035T3 (da) Mundplejemiddel
DE69926907T2 (de) Bleichungzusammensetzungen
DE69912619D1 (de) Zahnseide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1069913

Country of ref document: EP